FATAL ENCEPHALITIS DUE TO VARIANT-B HUMAN HERPESVIRUS-6 INFECTION IN A BONE MARROW-TRANSPLANT RECIPIENT

被引:291
|
作者
DROBYSKI, WR
KNOX, KK
MAJEWSKI, D
CARRIGAN, DR
机构
[1] MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53226
[2] MED COLL WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53226
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 330卷 / 19期
关键词
D O I
10.1056/NEJM199405123301905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human herpesvirus-6 (HHV-6) is the causative agent of exanthem subitum1 and febrile illnesses2 in children. More recently, HHV-6 has been shown to infect the recipients of bone marrow transplants and has been implicated in interstitial pneumonitis3,4 and bone marrow suppression5 after transplantation. The pathogenicity of HHV-6, however, has yet to be fully delineated in either immunocompetent or immunocompromised hosts. In some children with exanthem subitum, seizures, encephalopathy, and the detection of HHV-6 DNA in cerebrospinal fluid have provided circumstantial evidence that HHV-6 can infect the central nervous system6,7. Nevertheless, these studies have failed to document the direct. © 1994, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1356 / 1360
页数:5
相关论文
共 50 条
  • [21] Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients
    Chan, PKS
    Peiris, JSM
    Yuen, KY
    Liang, RHS
    Lau, YL
    Chen, FE
    Lo, SKF
    Cheung, CY
    Chan, TK
    Ng, MH
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (03) : 295 - 305
  • [22] Human herpes virus 6 fatal encephalitis in a bone marrow recipient
    Rodrigues, GD
    Nagendra, S
    Lee, CK
    De Magalhaes-Silverman, M
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1999, 31 (03) : 313 - 315
  • [23] Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation
    W Bethge
    R Beck
    G Jahn
    P Mundinger
    L Kanz
    H Einsele
    Bone Marrow Transplantation, 1999, 24 : 1245 - 1248
  • [24] Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation
    Bethge, W
    Beck, R
    Jahn, G
    Mundinger, P
    Kanz, L
    Einsele, H
    BONE MARROW TRANSPLANTATION, 1999, 24 (11) : 1245 - 1248
  • [25] PREVALENCE OF HUMAN HERPESVIRUS-6 VARIANT-A AND VARIANT-B INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS AS DETERMINED BY POLYMERASE CHAIN-REACTION AND SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE HYBRIDIZATION
    DROBYSKI, WR
    EBERLE, M
    MAJEWSKI, D
    BAXTERLOWE, LA
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (06) : 1515 - 1520
  • [26] MONOCLONAL-ANTIBODIES TO GLYCOPROTEIN-B DIFFERENTIATE HUMAN HERPESVIRUS-6 INTO 2 CLUSTERS, VARIANT-A AND VARIANT-B
    CAMPADELLIFIUME, G
    GUERRINI, S
    LIU, XM
    FOATOMASI, L
    JOURNAL OF GENERAL VIROLOGY, 1993, 74 : 2257 - 2262
  • [27] Encephalitis owing to human herpesvirus-6 after cardiac transplant
    Nash, PJ
    Avery, RK
    Tang, WHW
    Starling, RC
    Taege, AJ
    Yamani, MH
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) : 1200 - 1203
  • [28] HUMAN HERPESVIRUS-6 AND BONE-MARROW TRANSPLANTATION
    CARRIGAN, DR
    KNOX, KK
    BURD, EM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 885 - 885
  • [29] HUMAN HERPESVIRUS-6 AND BONE-MARROW TRANSPLANTATION
    CARRIGAN, DR
    BLOOD, 1995, 85 (01) : 294 - 295
  • [30] Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients
    Zerr, DM
    Gooley, TA
    Yeung, L
    Huang, ML
    Carpenter, P
    Wade, JC
    Corey, L
    Anasetti, C
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) : 763 - 771